Clinical Trial Update: Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessed safety and efficacy of RN1001 (Avotermin) in healthy male volunteers for skin scarring outcomes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Scar

Drugs mentioned

• RN1001 (Avotermin)

Snippet

Sponsor: Renovo | Conditions: Cicatrix | Phase 1, Phase 2 | Status: COMPLETED